CD8A and neoplasm: It effectively blocks tumor-infiltrating macrophage-mediated immune suppression, increases the number of CD8+ T cells within tumors, and suppresses the growth of both in situ and subcutaneous tumors in a CD8+ T cell-dependent manner (27).